🇺🇸 FDA
Patent

US 12280037

Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

granted A61KA61K31/4164A61K31/566

Quick answer

US patent 12280037 (Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof) held by EVOFEM BIOSCIENCES, INC. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EVOFEM BIOSCIENCES, INC.
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/4164, A61K31/566, A61K31/567, A61K31/69